FDA Recalls Stree Overlord Capsules Marketed Without Approval
R Thomas Marketing, LLC is recalling Stree Overlord capsules because they were marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA).
The agency’s classification
FDA (Drugs): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 5/5 (Critical).
Highest-severity recall. The hazard can cause serious injury or death. Stop using the product now and follow the agency's instructions.
Our severity reasoning: The agency classification is FDA Class I, which per the rubric mandates a score of 5 (Critical) or 4 (Severe); however, the rubric states 'If the agency's own classification is FDA Class I... never go below 4' and typically Class I implies a reasonable probability of serious adverse health consequences or death, aligning with the Critical label in the provided mapping where 5=Critical. Wait, the rubric says 5=Critical for 'FDA Class I'. Let me re-read. '5 Critical: FDA Class I...'. Yes, FDA Class I maps to 5.
Plain-English summary
R Thomas Marketing, LLC is recalling Stree Overlord, a product packaged in 10 small boxes containing 1 capsule per box. The product was distributed nationwide via Internet sales.
The FDA is recalling this product because it was marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA). This means the product has not been evaluated by the FDA for safety, efficacy, or quality.
Consumers who have purchased Stree Overlord should stop using the product and contact the distributor for further instructions.
The recalled product
- Product
- Stree Overlord, packaged in 10 small boxes / 1 capsule per box, Distributed by: R Thomas Marketing, LLC, Bronx, NY 10467
- Manufacturer
- R Thomas Marketing, LLC
- Category
- Drug — Unapproved Drug
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- all lots
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 24 recalled by R Thomas Marketing, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 24 products in this recall →Related recalls
Same manufacturer · R Thomas Marketing, LLC
See all →- SevereMan King capsules recalled for lack of FDA approval
FDA (Drugs) · 2016-06-01
- SevereFDA Recalls Black Storm Capsules Marketed Without Approval
FDA (Drugs) · 2016-06-01
- SevereFDA Recalls Zhen Gong Fu for Lack of Approved New Drug Application
FDA (Drugs) · 2016-06-01
- SevereBull's Genital Recalled for Marketing Without FDA Approval
FDA (Drugs) · 2016-06-01
- SeverePlant Vigra Recalled for Lack of FDA Approval
FDA (Drugs) · 2016-06-01
Same hazard · unapproved drug
See all →- CriticalBuy-Herbal Recalls Kian Pee Wan Capsules for Undeclared Drug Ingredients
FDA (Drugs) · 2026-08-19
- SevereMR. 7 Super capsules recalled as Class I over undeclared sildenafil
FDA (Drugs) · 2026-03-11
- SevereMojo Max Fusion capsules recalled as Class I over undeclared drug ingredients
FDA (Drugs) · 2026-03-11
- SevereSilintan herbal pills recalled as Class I for undeclared meloxicam
FDA (Drugs) · 2026-03-11
- SevereAgebox iKids-Growth Day Formula Capsules Recalled Over Undeclared Drug Ingredient
FDA (Drugs) · 2026-03-04
Similar recalls
- SevereSTREE OVERLORD capsules recalled for containing unapproved sildenafil
FDA (Drugs) · 2018-02-07
- SevereAndropharm Sten Z capsules recalled for lack of FDA approval
FDA (Drugs) · 2017-09-20
- SevereAndropharm M1 Alpha capsules recalled for lack of FDA approval
FDA (Drugs) · 2017-09-20
- ModerateUnapproved Aniracetam and Choline Capsules Recalled by FDA
FDA (Drugs) · 2013-04-10
- SevereMiss Slim capsules recalled for unapproved marketing distribution
FDA (Drugs) · 2021-09-01
- ModeratePalmer Natural Products Recalls Unapproved Oxiracetam and Choline Capsules
FDA (Drugs) · 2013-04-10